Pfizer-Mylan combo Viatris to slash up to 9000 jobs, shutter manufacturing plants in global cost-cutting drive – FiercePharma

A little less than a month after Pfizer’s Upjohn unit and Mylan successfully merged to create generics business Viatris, the company is already looking at ways to slash costs. Newly mintedViatris Friday laid out detailed plans for a global manufacturinginitiative that could put thousands of jobs on the line. By 2024 at the latest, the…